Antonio Gea-Leiva
Malaga, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.
Journal: The New England journal of medicine
Published: June 29, 2026
Update and review of treatment in achondroplasia.
Journal: Anales de pediatria
Published: February 23, 2026
Limb lengthening in achondroplasia: a cost-effectiveness analysis using a Markov model.
Journal: Orphanet journal of rare diseases
Published: February 10, 2026
Prospective Clinical Evaluation of Customized Titanium Occlusive Barriers with Window Modification for Guided Bone Regeneration: Radiographic and Histological Outcomes.
Journal: Biomimetics (Basel, Switzerland)
Published: January 18, 2026
Practical guidance for clinicians to optimise orthopaedic outcomes in achondroplasia: International Achondroplasia Forum guiding principles.
Journal: Bone
Published: November 11, 2025
Practical guidance for clinicians to optimise orthopaedic outcomes in achondroplasia: International achondroplasia forum guiding principles.
Journal: Bone
Published: November 11, 2025
Guided Bone Regeneration Using a Modified Occlusive Barrier with a Window: A Case Report.
Journal: Biomimetics (Basel, Switzerland)
Published: April 10, 2025
Effectiveness of Titanium Occlusive Barriers in Guided Bone Regeneration: A Prospective Analysis of Vertical and Horizontal Bone Augmentation.
Journal: Biomimetics (Basel, Switzerland)
Published: January 15, 2025
Oral Infigratinib Therapy in Children with Achondroplasia.
Journal: The New England journal of medicine
Published: November 18, 2024
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: May 24, 2024
Last Updated: 09/26/2026